Cancer Genetics CEO Moderates Panel Discussion With Thought Leaders in Biopharma at the BioNJ 2014 International BioPartnering Conference

By Jamie on April 10 2014

Panna Sharma, CEO of Cancer Genetics, Is Moderating a Panel Entitled “Partnering for a Balanced Portfolio:  Perspectives from Innovators, Partners, & Payers” RUTHERFORD, N.J., April 10, 2014 – Cancer Genetics, Inc. (Nasdaq: CGIX) (“CGI” or the “Company”), an emerging leader in DNA-based cancer diagnostics, announced that the Company is a sponsor of the BioNJ International […]

Continue Reading

Cancer Genetics Announces Launch of CALR Mutation Analysis Test to Assist in Diagnosis of Acute Leukemias & Myeloproliferative Neoplasms

By Jamie on April 4 2014

New Test Launch Extends CGI’s Leadership in Genomic Testing for Blood Cancers CALR Genetic Mutation Test Will Be A Part of CGI’s Comprehensive Focus on Leukemia RUTHERFORD, N.J., April 4, 2014 (GLOBE NEWSWIRE) — Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or the “Company”), an emerging leader in DNA-based cancer diagnostics, has launched a genetic diagnostic test for […]

Continue Reading

Cancer Genetics to Present New Data from Renal Cell Carcinoma Study at AACR

By Jamie on April 3 2014

Genomic Alterations Identified in Study Could Potentially Serve as Biomarkers for Metastasis in RCC RUTHERFORD, NJ – April 3, 2014 – Cancer Genetics, Inc. (NASDAQ: CGIX), an emerging leader in DNA-based diagnostics, announced today that a poster highlighting preliminary results of a study in clear cell Renal Cell Carcinoma (ccRCC) will be presented at the 105th Annual […]

Continue Reading